Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Hutano Diagnostics Ltd is developing a disease diagnostic and surveillance platform for quick disease diagnosis, tracking and outbreak spread prediction of emerging and dangerous pathogens (EDP), which are infectious and recurring in the African Region. EDP cause Ebola Virus Disease, Marburg Virus Disease, Lassa Fever, Rift Valley Fever, Crimean-Congo Haemorrhagic Fever and Dengue Haemorrhagic Fever. The platform consists of a digital rapid diagnostic test (RDT) and online database. The Hutano RDT provides a diagnosis from a simple finger prick blood sample in just 10 minutes. Through transferable IP, Hutano will scale its technology by developing a portfolio of RDTs for infectious diseases starting with an Ebola RDT, then a Multiplex RDT (EDP, Yellow Fever, Bacterial infection). The RDT component of the platform has a longer shelf life (> 3X) than present day RDT’s and does not need refrigeration during transportation and storage (key differentiators in our market). This significantly reduces distribution costs as well as complexity, and increases product penetration as 68% of African clinics do not have access to electricity. Our RDT is suitable for the realities of healthcare across Africa today.

Links to information about Hutano:

https://eship.ox.ac.uk/oxford-case-studies-hutano-diagnostics/

https://www.linkedin.com/company/hutano-diagnostics/?trk=public_profile_topcard_current_company

https://rhodesincubator.com/projects